XTX Topco’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

XTX Topco’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$762K	Buy	25,404 +2,185	+9%	+$72.3K	0.01%	1655
2025 Q4	$759K	Buy	23,219 +11,162	+93%	+$360K	0.02%	1244
2025 Q3	$418K	Sell	12,057 -27,746	-70%	-$888K	0.02%	1218
2025 Q2	$1.11M	Buy	+39,803	New	+$1.07M	0.05%	597
2025 Q1	–	Sell	-19,833	Closed	-$545K	–	2639
2024 Q4	$545K	Buy	19,833 +11,492	+138%	+$320K	0.04%	703
2024 Q3	$240K	Sell	8,341 -3,111	-27%	-$84.7K	0.02%	1334
2024 Q2	$284K	Buy	+11,452	New	+$325K	0.02%	999
2023 Q2	–	Sell	-8,416	Closed	-$325K	–	1557
2023 Q1	$325K	Buy	+8,416	New	+$346K	0.07%	588

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco's LKFT Position: Q1 2026 in Review

XTX Topco increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9.4% in Q1 2026, buying an estimated $72.3K and bringing the position to 25,404 shares worth $762K. The position accounts for 0.01% of the portfolio, ranked #1655.

XTX Topco first reported a position in LKFT in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.11M in Q2 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

XTX Topco held 25,404 shares of Lakefront Biotherapeutics American Depositary Shares worth $762K as of Q1 2026.
XTX Topco bought 2,185 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $72.3K.
Lakefront Biotherapeutics American Depositary Shares made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1655 holding.
XTX Topco first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and has held it in 8 quarters since.
XTX Topco's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.11M in Q2 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.